Table 4. Association between COVID-19 infection and clinical outcomes on crude and adjusted analysis.
| Parameter | Crude OR (95% CI) | P value | Adjusted OR (95% CI) | P value |
|---|---|---|---|---|
| Biochemical pregnancy | ||||
| Non COVID-19 group (n = 167) | 1 | 1 | ||
| COVID-19 group (n = 160) | 0.998 (0.645∼1.546) | 0.995 | 1.140 (0.715∼1.818) | 0.583 |
| Clinical pregnancy | ||||
| Non COVID-19 group (n = 167) | 1 | 1 | ||
| COVID-19 group (n = 160) | 1.016 (0.658∼1.569) | 0.942 | 1.107 (0.694∼1.764) | 0.670 |
| Ongoing pregnancy | ||||
| Non COVID-19 group (n = 167) | 1 | 1 | ||
| COVID-19 group (n = 160) | 1.109 (0.717∼1.714) | 0.642 | 1.194 (0.746∼1.910) | 0.461 |
| Early abortion | ||||
| Non COVID-19 group (n = 167) | 1 | 1 | ||
| COVID-19 group (n = 160) | 0.649 (0.245∼1.718) | 0.384 | 0.694 (0.250∼1.931) | 0.484 |
| Live birth | ||||
| Non COVID-19 group (n = 167) | 1 | 1 | ||
| COVID-19 group (n = 160) | 0.974 (0.629∼1.509) | 0.908 | 0.953 (0.597∼1.523) | 0.842 |
Notes.
Logistic analyses (adjusted for age, BMI, infertility duration, endometrial thickness, number of embryos transferred, transfer of ≥1 good-quality embryo and luteal support protocols).